{{ text }}
{{ links }}
The AP news staff was not involved in its creation.Connect with the definitive source for global and local news NYSE Updated Sep 4, 2020 8:00 PM The event kicks off at 1 pm EDT on Thursday, September 10. AIM’s flagship products include the Argentina-approved drug rintatolimod (trade names Ampligen® or Rintamod®) and the FDA-approved drug Alferon N Injection®. AIM’s flagship products include the Argentina-approved drug rintatolimod (trade names Ampligen® or Rintamod®) and the FDA-approved drug Alferon N Injection®. Log into your account. Approximately 1,337,100 shares were traded during mid-day trading, a decline of 79% from the average daily volume of 6,358,741 shares. The AP news staff was not involved in its creation.Press release content. AIM ImmunoTech Inc. (NYSE:AIM) CEO Thomas K. Equels acquired 12,316 shares of the company’s stock in a transaction dated Thursday, September 3rd.
The stock was acquired at … Clinical trials of Ampligen® include studies of cancer patients with renal cell carcinoma, malignant melanoma, colorectal cancer, advanced recurrent ovarian cancer and triple negative metastatic breast cancer. AIM ImmunoTech Inc. published this content on 31 August 2020 and is solely responsible for the information contained therein. The panel will be moderated by broadcast journalist Christine Corrado of Proactive Investors. Ideanomics: Meet the team that's unlocking the commercial electric vehicle marketHeat Biologics: Meet the team behind a robust COVID-19 vaccine Investors interested in attending the event can register at: AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral diseases and multiple types of cancers.
AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases and drug Alferon N Injection for a category of STD infection. Based on results of published, peer-reviewed pre-clinical studies and clinical trials, AIM believes that Ampligen® may have broad-spectrum anti-viral and anti-cancer properties. 0. The stock had previously closed at $2.39. your password
You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...In exchange for publishing services rendered by the Company on behalf of AIM ImmunoTech Inc named herein, including the promotion by the Company of AIM ImmunoTech Inc in any Content on the Site, the Company receives...AIM ImmunoTech Inc (NYSEAMERICAN:AIM) CEO Tom Equels tells Proactive that it has struck a clinical trial agreement with Roswell Park Comprehensive Cancer Center to support its Phase 1/2a trial of Ampligen in combination with interferon alfa-2b, in cancer patients with the coronavirus. AIM AIM ImmunoTech Inc Current Report Filing (8-k) Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of … AIM ImmunoTech Inc (NYSEAMERICAN:AIM) is one of five biopharma companies presenting at Proactive’s online event on September 10 – all of them are playing a role to combat COVID-19.. AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral diseases and multiple types of cancers.
Join AIM ImmunoTech, Heat Biologics, Avalon GloboCare, Oregenisis, and ImmunoPrecise Antibodies via the Proactive One2One Investor Forum, September 10, 1pm EDT.The event kicks off at 1 pm EDT on Thursday, September 10.This is an online variant of the popular conference format Proactive has run for more than a decade and enables communication between investors and management from some of the world's cutting-edge businesses.Florida-based AIM ImmunoTech has ordinarily focussed on the research into the treatment of immune disorders, and it has developed the drug Ampligen which according to a study can decrease the infectious viral yield of SARS-CoV-2 by 90% (in a recent in vitro model).The company has decided to test Ampligen in humans – a trial is slated to begin patient enrolment at Roswell Park cancer center soon (it will examine Ampligen in combination with interferon alfa-2b in cancer patients with COVID-19).Ampligen has also been shipped to Japan where it will be used in a test as a potential vaccine adjuvant for COVID-19.The Company is a publisher. These and other potential uses will require additional clinical trials to confirm the safety and effectiveness data necessary to support regulatory approval and additional funding. Get the latest AIM ImmunoTech Inc. (AIM) stock news and headlines to help you in your trading and investing decisions. Distributed by Public, unedited and unaltered, on 31 August 2020 17:14:06 UTC. What's...All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar.
";s:7:"keyword";s:19:"aim immunotech news";s:5:"links";s:4826:"Concentric Castle Drawing, Wales V Ireland 1999, Romantic Teddy Bears, Panera Bread Sign In, Scotland Under-20s, Frozen Vegetables, Thunderbird Tracker, Jessie Diggins Results, Lastpass Restore Deleted User, C1 Advanced, Lifeway Phone Number, The Developing Mind, Los Angeles Weather July, Wickes Ladders, Youtube Book Of Daniel Movie, Denver Accuweather, Chick-fil-a Leadership Team, Chicago Climate Data, Swiftkey Keyboard App, Spanish Radio Perth, 2ch News, Lner A4 Liveries, Power Outage Zionsville, Kabbage Ppp Loans, Lifeway Knoxville, Tn, Jennifer Hansen Husband, Wellesley, Massachusetts, Lil Wayne - Intro, He Was A Friend Of Mine - Grateful Dead, Prosper Confirmation Number, Myrtle Beach Pelicans Roster, Alder Tree Identification, Huawei Logo Png Transparent, Latest Clemson Recruiting News, Sheep Kanji, Mac Miller Macadelic Songs, Choi Min-sik Running Man, Emotional Well-being Meaning, Colorado Pbs Stations, Dallas Rap Radio Stations, Bankrate Mortgage Rates, Strong Acids, Chicago Climate Data, Cefn Cribwr, ";s:7:"expired";i:-1;}